Lemaitre Vascular (LMAT) Leases (2019 - 2026)

Lemaitre Vascular (LMAT) has 8 years of Leases data on file, last reported at $19.8 million in Q1 2026.

• Quarterly Leases rose 22.17% year-over-year to $19.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $19.8 million (up 22.17% YoY) and the FY2025 annual result came in at $15.8 million, down 6.0% from the prior year.
• Leases improved to $19.8 million in Q1 2026 per LMAT's latest filing, from $15.8 million in the prior quarter.
• Across five years, Leases topped out at $19.8 million in Q1 2026 and bottomed at $14.7 million in Q1 2022.
• The 5-year median for Leases is $16.2 million (2025), against an average of $16.5 million.
• The widest annual swing landed in 2025, when Leases fell 8.78%; it then rose 22.17% in 2026.
• Tracing LMAT's Leases over 5 years: stood at $15.6 million in 2022, then climbed by 15.31% to $18.0 million in 2023, then retreated by 6.98% to $16.8 million in 2024, then decreased by 6.0% to $15.8 million in 2025, then gained by 25.82% to $19.8 million in 2026.
• Per Business Quant, the three latest LMAT Leases figures stand at $19.8 million (Q1 2026), $15.8 million (Q4 2025), and $16.0 million (Q3 2025).

Peer Comparison